Premium
Influenza Nanovaccines: A Universal Influenza Nanovaccine for “Mixing Vessel” Hosts Confers Potential Ability to Block Cross‐Species Transmission (Adv. Healthcare Mater. 16/2019)
Author(s) -
Ding Peiyang,
Jin Qianyue,
Zhou Wen,
Chai Yongxiao,
Liu Xiao,
Wang Yao,
Chen Xinxin,
Guo Junqing,
Deng Ruiguang,
Gao George F.,
Zhang Gaiping
Publication year - 2019
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201970065
Subject(s) - virology , viral matrix protein , transmission (telecommunications) , porcine circovirus , capsid , biology , ectodomain , virus , genetics , computer science , telecommunications , receptor
In article number 1900456 by Gaiping Zhang and co‐workers, an influenza nanovaccine for “mixing vessel” hosts is developed. The nanovaccine is constructed by displaying conserved ectodomain of influenza matrix protein 2 (M2e) on self‐assembling capsid protein (Cap) of porcine circovirus type 2 (PCV2). The nanovaccine provides dual protection against different subtypes of influenza and PCV2 in mouse and pig models, and confers potential ability to block cross‐species transmission.